Clinical Trial

LA Improves the Prognosis of Patients With ICVD After Surgery

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Ischemic cerebrovascular disease will cause serious harm to the life and safety of patients, and the treatment prognosis is poor. Numerous clinical trials have demonstrated that probiotics can improve cognitive function in people under multimodal. We have previously found that Lactobacillus acidophilus administration could improve cognitive impairment in MCAO and BCAS mice. Therefore, Based on the above research background and the basis of previous studies, we believe that the administration of Lactobacillus acidophilus solid drink (pure Lactobacillus acidophilus strain) can improve the cognitive function of patients with cerebral ischemia through the "brain-gut axis".
Trial Details
NCT Number NCT05656209
Lead Sponsor Huaqiu Zhang
Conditions Ischemia; Cerebrovascular, Cognitive Impairment
Enrollment 236 participants
Start Date 2022-12-18
Primary Completion 2022-12-18 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2022-12-19